Targeting IL 18/IL18BP to prevent NASH-related hepato-cellular carcinoma
- Genetic analysis coupled to application of isotopic techniques to the study of Mauriac Syndrome
- Administration par PIPAC du nab-paclitaxel et cisplatine dans la carcinose péritonéale